Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$538.60 -4.02 (-0.74%)
At close: Nov 13, 2026 · 4:00 PM EST

Vertex Pharmaceuticals (VRTX) Change in Accrued Expenses (2009 - 2026)

Updated

Vertex Pharmaceuticals' Change in Accrued Expenses was -$7.4 million in Q3 2026, compared with $332.9 million a year earlier.

Analysis

Vertex Pharmaceuticals (VRTX) Change in Accrued Expenses (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vertex Pharmaceuticals' Change in Accrued Expenses was -$378.9 million through Sep 30, 2026; for FY2025, it was -$116.9 million.

  • In earlier years, Change in Accrued Expenses was $212.9 million in FY2024 (-50.4%), $429.4 million in FY2023 (-20.8%), $542.5 million in FY2022 (+77.6%) and $305.4 million in FY2021 (+149.9%).
  • Quarterly Change in Accrued Expenses has moved between -$664.5 million (Q4 2025) and $485.5 million (Q2 2022) over five years.
  • Compared with a year earlier, Change in Accrued Expenses was higher in three of the last five quarters, with growth averaging 19.8%.
  • The best year-over-year quarter for Change in Accrued Expenses over five years was Q3 2022 (growth of 195.3%); the worst was Q1 2025 (a decline of 75.2%).
  • Per Business Quant data, VRTX's Change in Accrued Expenses in the three quarters before Q3 2026 was $222.5 million (Q2 2026), $70.5 million (Q1 2026) and -$664.5 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.41 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 983.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 756.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 136.55 Bn 104.28 Bn 2.91 Bn -7.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -7.40 Mn
Jun 30, 2026 222.50 Mn
Mar 31, 2026 70.50 Mn
Dec 31, 2025 -664.50 Mn
Sep 30, 2025 332.90 Mn
Jun 30, 2025 166.60 Mn
Mar 31, 2025 48.10 Mn
Dec 31, 2024 -320.10 Mn
Sep 30, 2024 170.60 Mn
Jun 30, 2024 168.30 Mn
Mar 31, 2024 194.10 Mn
Dec 31, 2023 -356.70 Mn
Sep 30, 2023 368.70 Mn
Jun 30, 2023 276.70 Mn
Mar 31, 2023 140.70 Mn
Dec 31, 2022 -437.80 Mn
Sep 30, 2022 433.20 Mn
Jun 30, 2022 485.50 Mn
Mar 31, 2022 61.60 Mn
Dec 31, 2021 51.20 Mn
API Access

Vertex Pharmaceuticals Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=VRTX&period=max&api_key=YOUR_API_KEY